The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.
The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.
The global telemedicine market increased 35% from 2019 to 2020, exceeding $55bn. Forecasts suggest the market could reach nearly $300bn by 2028. (Source: "Telemedicine Market Size, Share & Trends Analysis Report By Component" Grand View Research, Feb 2021)
In 2019, an estimated half of the global population lacked essential health care services. As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide. (Source: World Economic Forum)
The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.
Presently, Global X UCITS ETFs are best accessed either in consultation with a financial advisor or a broker qualified to purchase stocks, ETFs and other securities on behalf of clients. Brokerage and other fees may apply. Global X does not make any recommendations or endorsements.
| Primary Ticker | EDOC |
| Primary ISIN | IE00BLR6QB00 |
| Inception Date | 17 Dec 2020 |
| Bloomberg Index Ticker | SOLEDOC |
| Index Provider | Solactive AG |
| Management Style | Physical - Full Replication |
| Management Company | Global X Management Company |
| Custodian | BBH |
| Domicile | Ireland |
| Fund AUM | $11,984,427.47 |
| Number of Holdings | 40 |
| Total Expense Ratio | 0.68% |
| Ongoing Charges | 0.68% |
| Distribution Frequency | Semi-Annually |
| UCITS Compliant | Yes |
| ISA Eligibility | Yes |
| SIPP Available | Yes |
| UK Reporting Status | Yes |
Citigroup Global Markets, DRW Europe BV, Flow Traders BV, GHCO LLP, HSBC Bank PLC, Jane Street Financial Ltd, Mirae Asset Securities UK Ltd, Societe Generale SA, Susquehanna Intl Ltd
Denmark, Finland, Germany, Ireland, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, UK
| Exchange | Trading Currency |
Ticker | Listing Date |
SEDOL | Net Asset Value (NAV) |
Shares Outstanding |
Net Assets |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | USD | EDOC LN | 18 Dec 2020 | BLR6Q54 | $15.17 (2.14%) | 740,000 | $11,225,993.90 |
| Deutsche Börse Xetra | EUR | DDOC GY | 04 Feb 2021 | BLR6Q76 | |||
| Bolsa Mexicana De Valores | MXN | EDOCU MX | 25 Mar 2021 | ||||
| SIX Swiss Exchange | CHF | EDOC SW | 16 Jul 2021 | BNT8T75 | |||
| Borsa Italiana | EUR | EDOC IM | 09 Aug 2021 | BMCHV21 |
| Exchange | Trading Currency |
Ticker | Listing Date |
SEDOL | Net Asset Value (NAV) |
Shares Outstanding |
Net Assets |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | GBP | EDOG LN | 18 Dec 2020 | BLR6Q98 | $15.17 (2.15%) | 50,000 | $758,433.57 |
As of 31 Aug 2021 |
Fund | Index | Relative |
|---|---|---|---|
| Last 12 Months | -- | -- | -- |
Returns not available as there is less than 12 months of performance history.
| % of Net Assets | ||
|---|---|---|
| Health Care | 63.2 | |
| Information Technology | 25.1 | |
| Communication Services | 8.9 | |
| Industrials | 1.9 | |
| Financials | 0.7 | |
| Materials | 0.3 | |
Source: AltaVista Research, LLC
| % of Net Assets | ||
|---|---|---|
| United States | 86.6 | |
| China | 5.0 | |
| Japan | 4.1 | |
| Germany | 2.3 | |
| Hong Kong | 2.1 | |
Source: AltaVista Research, LLC
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 5.58 | DXCM | DEXCOM INC | B0796X4 | 563.14 | 1,188 | 669,010.32 |
| 5.47 | A | AGILENT TECHNOLOGIES INC | 2520153 | 173.94 | 3,769 | 655,579.86 |
| 5.38 | TNDM | TANDEM DIABETES CARE INC | BF3W461 | 122.43 | 5,268 | 644,961.24 |
| 4.82 | 2413 JP | M3 INC | B02K2M3 | 80.90 | 7,133 | 577,087.40 |
| 4.76 | LH | LABORATORY CP | 2586122 | 295.93 | 1,929 | 570,848.97 |
| 4.76 | OMCL | OMNICELL INC | 2789523 | 160.58 | 3,549 | 569,898.42 |
| 4.65 | ILMN | ILLUMINA INC | 2613990 | 447.01 | 1,246 | 556,974.46 |
| 4.50 | UNH | UNITEDHEALTH GROUP INC | 2917766 | 420.16 | 1,284 | 539,485.44 |
| 4.38 | NUAN | NUANCE COMMUNICATIONS INC | 2402121 | 55.10 | 9,521 | 524,607.10 |
| 4.22 | CERN | CERNER CORP | 2185284 | 75.04 | 6,741 | 505,844.64 |
| Holdings are subject to change. | ||||||
The value of an investment in ETFs may go down as well as up and past performance is not a reliable indicator of future performance.
Trading in ETFs may not be suitable for all types of investors as they carry a high degree of risk. You may lose all of your initial investment. Only speculate with money you can afford to lose. Changes in exchange rates may also cause your investment to go up or down in value. Tax treatment depends on the individual circumstances of each client and may be subject to change in the future. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice. Investors should refer to the section entitled “Risk Factors” in the relevant prospectus for further details of these and other risks associated with an investment in the securities offered by the Issuer.